This web site was copied prior to January 20, 2005. It is now a Federal record managed by the National Archives and Records Administration. External links, forms, and search boxes may not function within this collection. Learn more.   [hide]
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Other Federal Agency : Department of Defense

Include trials that are no longer recruiting patients.

1 study was found.
1.RecruitingUrokinase-plasminogen activator (uPA) inhibitor WX-UK1 in combination with Capecitabine in Advanced Malignancies
Condition: Advanced malignancies

U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act